Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Cancer. 2011 Sep 21;118(10):2726–2734. doi: 10.1002/cncr.26551

Table 1.

Sample Characteristics by Baseline Test Preference: Univariable Analyses (n=1,224)

Total sample
characteristics (%)

na % FOBT
n=425
34.7%
COL
n=503
41.1%
SIG
n=155
12.7%
BE
n=70
5.7%
No preference
n=71
5.8%
p-valueb
Age - mean (SD) 55.6 (4.4) 55.2 (4.2) 55.7 (4.4) 56.0 (4.4) 55.3 (4.8) 56.5 (4.4) 0.702
Race 0.286
White 428 35.0 38.8 39.0 11.7 3.0 7.5
African American 576 47.1 33.2 42.9 12.8 7.6 3.7
Hispanic/other 220 18.0 30.9 40.4 14.6 5.9 8.2
Gender 0.255
Female 725 59.2 36.3 40.0 13.7 5.9 4.1
Male 499 40.8 32.5 42.7 11.2 5.4 8.2
Marital status 0.950
Married/partnered 746 60.9 34.4 40.8 12.9 5.4 6.6
Not married/divorced/widowed 473 38.6 35.3 41.9 12.5 6.3 4.0
Employment status 0.926
Employed (Full and/or Part time) 988 80.7 34.6 41.3 13.0 5.6 5.6
Not employed (includes retired) 228 18.6 34.7 41.2 11.8 6.6 5.7
Educational attainment 0.418
< High school or HS Grad 305 24.9 33.8 42.0 12.1 6.6 5.6
Some college 412 33.7 36.2 41.3 11.2 6.6 4.9
Bachelor’s degree 254 20.8 35.8 39.4 11.4 5.5 7.9
Post-college (graduate degree) 246 20.1 32.5 41.9 17.5 3.7 4.5
Family history of CRC 0.021
Yes 85 6.9 29.4 56.5 7.1 3.5 3.5
No 1139 93.1 35.1 40.0 13.1 5.9 6.0
Ever had CRC screening test 0.186
Yes 628 51.3 32.6 43.5 12.7 6.1 5.1
No 596 48.7 36.9 38.6 12.6 5.4 6.5
FOBTc 388 61.8 36.1 43.0 11.6 5.7 3.6 0.110
COLc 135 22.0 27.4 50.4 11.1 4.4 6.7 0.152
SIGc 190 30.3 27.4 45.3 19.5 4.2 3.7 0.003
BEc 245 39.0 32.7 40.8 9.8 10.6 6.1 0.399
MD ever recommended any CRC screening test <0.001
Yes 616 50.3 29.1 45.9 15.1 5.0 4.9
No 608 49.7 40.5 36.2 10.2 6.4 6.7
FOBTd 78 12.7 44.9 37.2 12.8 2.6 2.6 0.012
COLd 319 51.8 24.4 53.9 14.1 4.1 3.4 0.001
SIGd 59 9.6 25.4 42.4 23.7 6.8 1.7 0.163
BEd 10 1.6 40.0 50.0 10.0 0.0 0.0 0.791
Non-specific recommendationd 148 24.0 31.8 35.1 16.2 8.8 8.1 0.090
Preference for decision making 0.078
Patient-based 599 48.9 38.7 38.1 13.5 4.3 5.3
Shared 499 40.8 30.7 44.7 12.2 7.0 5.4
Doctor-based 119 9.7 32.8 41.2 10.9 7.6 7.6
Stage of readiness for CRC screening at baseline <0.001
Not thinking of getting tested (PC) 95 7.8 59.0 16.8 9.5 8.4 6.3
Considering getting tested (C) 219 17.9 39.7 34.3 11.0 7.3 7.8
Think I should get tested (C) 182 14.9 45.1 30.2 8.8 9.9 6.0
Probably will get tested (C) 268 2.2 33.2 46.3 14.2 3.7 2.6
I am committed to getting tested (P) 456 3.7 24.3 50.9 14.9 4.0 5.9
Test specific self efficacy
FOBT (very confident) 719 59.4 37.6 40.1 12.0 5.3 5.2 0.107
COL (very confident) 602 49.5 27.1 52.3 11.8 4.0 4.8 <0.001
SIG (very confident) 547 44.7 28.5 44.8 16.3 4.8 5.7 <0.001
BE (very confident) 501 40.9 31.3 45.1 11.8 5.8 6.0 0.036
Comparative risk 0.005
Less likely to develop CRC 336 27.4 42.9 35.4 12.5 4.5 4.8
Equally likely to develop CRC 641 52.4 33.2 42.3 13.6 6.2 4.7
More likely to develop CRC 215 17.6 27.4 47.0 11.6 6.5 7.4
Worry about CRC <0.001
Never 510 41.7 40.8 35.1 12.9 5.7 5.5
Rarely 396 32.4 35.9 42.7 12.4 4.3 4.8
Sometimes 262 21.4 26.0 47.0 12.2 8.0 6.9
Most of the time 31 2.5 6.4 67.7 12.9 9.7 3.2
All the time 15 1.2 13.3 60.0 20.0 0.0 6.7
CRC knowledge 2.5 (0.9) 2.4 (1.0) 2.6 (0.9) 2.5 (0.9) 2.4 (1.0) 2.3 (0.9) 0.191
Pros of CRC screening 3.5 (0.4) 3.4 (0.4) 3.5 (0.4) 3.4 (0.4) 3.5 (0.4) 3.3 (0.5) 0.041
Cons of CRC screening 1.7 (0.6) 1.8 (0.6) 1.7 (0.6) 1.7 (0.6) 1.9 (0.7) 1.7 (0.6) 0.876
a

Missing values ranged from zero for age to 34 CRC test-specific MD recommendation among those answering “yes” to MD ever recommended CRC screening test.

b

BE and “no preference” are excluded from chi square analyses. P-values <0.10 are considered statistically significant for purposes of variable selection to the multivariate model.

c

Test-specific percentages reflect percent of those answering “yes” to general screening question (n=628). P-value reflects comparisons between those ever having specific colon cancer screening test (yes/no) and baseline preferences. Categories are not mutually exclusive; participants could respond “yes” to more than one test.

d

Test-specific percentages reflect percent of those answering “yes” to general recommendation question (n=616). P-value reflects comparisons between those ever having a physician recommendation for that specific test (yes/no) and baseline preferences. Categories are not mutually exclusive; participants could respond “yes” to more than one test recommendation.